Women's Health Issues
Volume 19, Issue 5 , Pages 344-351 , September 2009

Exposure to High-Risk Genital Human Papillomavirus and Its Association with Risky Sexual Practices and Laboratory-Confirmed Chlamydia Among African-American Women

  • Puja Seth, PhD

      Affiliations

    • Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia
    • Emory Center for AIDS Research, Social and Behavioral Sciences Core, Atlanta, Georgia
    • Corresponding Author InformationCorrespondence to: Puja Seth, PhD, 1520 Clifton Road NE, Room 218, Atlanta, GA 30322. Phone: 404-727-8673; fax: 404-712-4299.
    • ,
  • Gina M. Wingood, ScD

      Affiliations

    • Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia
    • Emory Center for AIDS Research, Social and Behavioral Sciences Core, Atlanta, Georgia
    • ,
  • LaShun S. Robinson, PhD

      Affiliations

    • Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia
    • ,
  • Ralph J. DiClemente, PhD

      Affiliations

    • Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, Georgia
    • Emory Center for AIDS Research, Social and Behavioral Sciences Core, Atlanta, Georgia
    • Emory University School of Medicine, Department of Medicine (Infectious Diseases), Emory University, Atlanta, Georgia

Received 17 September 2008 ,Revised 8 June 2009 ,Accepted 9 June 2009.

References 

  1. Ault KA. Effect of prophylactic human papillomavirus L1 virus-like particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of 4 randomised clinical trials. Lancet. 2007;369:1861–1868
  2. Brown DR, Legge D, Qadadri B. Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sexually Transmitted Diseases. 2002;29:763–768
  3. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. Journal of Infectious Diseases. 2005;191:182–192
  4. Burk RD, Ho GY, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. Journal of Infectious Diseases. 1996;174:679–689
  5. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PAC, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. Journal of the American Medical Association. 1999;282:1458–1465
  6. Carpiano RM, Flocke SA, Frank SH, Stange KC. Tools, teamwork, and tenacity: An examination of family practice office system influences on preventive service delivery. Preventive Medicine. 2003;36:131–140
  7. Chao C, Slezak JM, Coleman KJ, Jacobsen SJ. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. American Journal of Public Health. 2009;99:1137–1142
  8. Datta SD, Koutsky LA, Ratelle S, Unger ER, Shlay J, McClain T, et al. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003–2005. Annals of Internal Medicine. 2008;148:493–500
  9. DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk-reduction intervention for young African American women. JAMA. 1995;274:1271–1276
  10. Division of STD Prevention. (1999). Prevention of genital HPV infection and sequelae: Report of an External Consultants' Meeting. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention.
  11. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. The Journal of the American Medical Association. 2007;297:813–819
  12. Goldie SJ, Grima D, Kohli M, Wright TC, Weinstein M, Franco EA. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. International Journal of Cancer. 2003;106:896–904
  13. Gravitt P, Lacey J, Brinton L, Barnes WA, Kornegay JR, Greenberg MD, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiology Biomarkers and Prevention. 2001;10:95–100
  14. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, et al. Improved amplification of genital human papillomavirus. Journal of Clinical Microbiology. 2000;38:357–361
  15. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 HPV types from L1 consensus PCR products using a single hybridization, reverse-line blot detection method. Journal of Clinical Microbiology. 1998;36:3020–3027
  16. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet. 2006;367:1247–1255
  17. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine. 1998;338:423–428
  18. Hogewoning CJA, Bleeker MCG, Van Den Brule AJC, Voorhorst FJ, Snijders PJF, Berkhof J, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trial. International Journal of Cancer. 2003;107:811–816
  19. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989;
  20. Hosmer DW, Taber S, Lemeshow S. The importance of assessing the fit of logistic regression models: A case study. American Journal of Public Health. 1992;81:1630–1635
  21. Hutchinson DJ, Klein KC. Human papillomavirus disease and vaccines. American Journal of Health-System Pharmacy. 2008;65:2105–2112
  22. Kahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high risk human papillomavirus infection. Obstetrics & Gynecology. 2007;110:87–95
  23. Kaiser Permanente. (2008). 2009 Medicare Part D formulary. Available: https://prospectivemembers.kaiserpermanente.org. Accessed June 8, 2009.
  24. Keating KM, Brewer NT, Gottlieb SL, Liddon N, Ludema C, Smith JS. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. Journal of Adolescent Health. 2008;43:S61–S67
  25. Kempe A, Daley MF, Parashar UD, Crane LA, Beaty BL, Stokley S, et al. Will pediatricians adopt the new rotavirus vaccine?. Pediatrics. 2007;119:1–10
  26. Kjaer SK, Svare EL, Worm AM, Wallboomers JM, Meijer CJ, van den Brule AJ. Human papillomavirus infection in Danish female sex workers: Decreasing prevalence with age despite continuously high sexual activity. Sexually Transmitted Diseases. 2000;27:438–445
  27. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chose young Danish women with normal Pap smear: Are there different risk profiles for oncogenic and nononcogenic HPV types?. Cancer Epidemiology, Biomarkers, and Prevention. 1997;6:799–805
  28. Koutsky LA. Epidemiology of genital human papillomavirus infection. American Journal of Medicine. 1997;102:3–8
  29. Manhart LE, Holmes KK, Koutsky LA, Wood TR, Kenney DL, Feng Q, et al. Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy. Sexually Transmitted Diseases. 2006;33:502–508
  30. Manhart LE, Koutsky LA. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sexually Transmitted Diseases. 2002;29:725–735
  31. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2007;56:1–24
  32. McInerny TK, Cull WL, Yudkowsky BK. Physician reimbursement levels and adherence to American Academy of Pediatrics well-visit and immunization recommendations. Pediatrics. 2005;115:833–838
  33. Middleman AB. Adolescent immunizations: Policies to provide a shot in the arm for adolescents. Journal of Adolescent Health. 2007;41:109–118
  34. Molano M, Posso H, Weiderpass E, Van Den Brule AJC, Ronderos M, Franceschi S, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. British Journal of Cancer. 2002;87:324–333
  35. Moscicki AB, Burt VG, Kanowitz S, Darragh T, Shiboski S. The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women. Cancer. 1999;85:1139–1144
  36. Moscicki AB, Ellenberg JH, Farhat S, Xu J. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: Risk factors and differences, by phylogenetic type. Journal of Infectious Diseases. 2004;190:37–45
  37. Paavonen J, Jenkins D, Bosch F, Naud P, Salmeron C, Wheeler S, et al. Efficacy of a prophylactic adjuvant bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomized controlled trial. Lancet. 2007;369:2161–2170
  38. Paavonen J, Lehtinen M. Introducing human papillomavirus vaccines-questions remain. Annals of Medicine. 2008;40:162–166
  39. Revzina NV, DiClemente RJ. Prevalence and incidence of human papillomavirus infection in women in the USA: A systematic review. International Journal of STD and AIDS. 2005;16:528–537
  40. Scarinci IC, Garces-Palacio IC, Partridge EE. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. Journal of Women's Health. 2007;16:1224–1233
  41. Shah K, Daniel R, Tennant M, Shah N, McKee KT, Gaydos CA, et al. Diagnosis of human papillomavirus infection by dry vaginal swabs in military women. Sexually Transmitted Infections. 2001;77:260–264
  42. Shew ML, Fortenberry D, Tu W, Juliar BE, Batteiger BE, Qadadri B, et al. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Archives of Pediatrics and Adolescent Medicine. 2006;160:151–156
  43. Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. Journal of Infectious Diseases. 2002;185:324–331
  44. Stange KC, Flocke SA, Goodwin MA, Kelly RB, Zyzanski SJ. Direct observation of rates of preventive service delivery in community family practice. Preventive Medicine. 2000;31:167–176
  45. Stange KC, Goodwin MA, Zyzanski SJ, Dietrich AJ. Sustainability of a practice-individualized preventive service delivery intervention. American Journal of Preventive Medicine. 2003;25:296–300
  46. Tarkowski TA, Koumans EH, Sawyer M, Pierce A, Black CM, Papp JR, et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. Journal of Infectious Diseases. 2004;189:46–50
  47. Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, Iversen OE, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. British Journal of Cancer. 2006;95:1459–1466
  48. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspectives in Sexual and Reproductive Health. 2004;36:6–10
  49. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, et al. Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women. Obstetrical & Gynecological Survey. 2006;61:639–640
  50. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. American Journal of Epidemiology. 2003;157:218–226
  51. Wise PH. The anatomy of a disparity in infant mortality. Annual Review of Public Health. 2003;24:341–362
  52. Wright TC, Denny L, Kruhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Journal of the American Medical Association. 2000;283:81–86
  53. Young TK, McNicol P, Beauvais J. Factors associated with human papillomavirus infection detected by polymerase chain reaction among urban Canadian aboriginal and non-aboriginal women. Sexually Transmitted Diseases. 1997;24:293–298
  54. Zimet GD. Improving adolescent health: Focus on HPV vaccine acceptance. Journal of Adolescent Health. 2005;37:S17–S23

 Supported by grant R01-MH62717, from the National Institute of Health, awarded to the second author.

PII: S1049-3867(09)00064-4

doi: 10.1016/j.whi.2009.06.001

Women's Health Issues
Volume 19, Issue 5 , Pages 344-351 , September 2009

Article Tools